AU2005282182A1 - Human milk fortifiers and methods for their production - Google Patents
Human milk fortifiers and methods for their production Download PDFInfo
- Publication number
- AU2005282182A1 AU2005282182A1 AU2005282182A AU2005282182A AU2005282182A1 AU 2005282182 A1 AU2005282182 A1 AU 2005282182A1 AU 2005282182 A AU2005282182 A AU 2005282182A AU 2005282182 A AU2005282182 A AU 2005282182A AU 2005282182 A1 AU2005282182 A1 AU 2005282182A1
- Authority
- AU
- Australia
- Prior art keywords
- milk
- fortifier
- human
- fortified
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000020256 human milk Nutrition 0.000 title claims description 79
- 210000004251 human milk Anatomy 0.000 title claims description 76
- 238000000034 method Methods 0.000 title claims description 29
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 235000013336 milk Nutrition 0.000 claims description 79
- 239000008267 milk Substances 0.000 claims description 79
- 210000004080 milk Anatomy 0.000 claims description 79
- 235000018102 proteins Nutrition 0.000 claims description 42
- 102000004169 proteins and genes Human genes 0.000 claims description 42
- 108090000623 proteins and genes Proteins 0.000 claims description 42
- 239000003925 fat Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 21
- 230000028327 secretion Effects 0.000 claims description 19
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 18
- 239000000470 constituent Substances 0.000 claims description 18
- 239000008101 lactose Substances 0.000 claims description 18
- 235000014633 carbohydrates Nutrition 0.000 claims description 14
- 150000001720 carbohydrates Chemical class 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- 239000011575 calcium Substances 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 235000015097 nutrients Nutrition 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 230000000153 supplemental effect Effects 0.000 claims description 9
- 102000011632 Caseins Human genes 0.000 claims description 8
- 108010076119 Caseins Proteins 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- 241001591005 Siga Species 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 7
- 230000006651 lactation Effects 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 102000016943 Muramidase Human genes 0.000 claims description 6
- 108010014251 Muramidase Proteins 0.000 claims description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 6
- 235000020189 fortified milk Nutrition 0.000 claims description 6
- 208000018773 low birth weight Diseases 0.000 claims description 6
- 231100000533 low birth weight Toxicity 0.000 claims description 6
- 229960000274 lysozyme Drugs 0.000 claims description 6
- 235000010335 lysozyme Nutrition 0.000 claims description 6
- 239000004325 lysozyme Substances 0.000 claims description 6
- 238000009928 pasteurization Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 235000013350 formula milk Nutrition 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 230000002028 premature Effects 0.000 claims description 4
- -1 25 alpha-lactalbimin Proteins 0.000 claims description 3
- 230000009920 chelation Effects 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000001223 reverse osmosis Methods 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- 108010028780 Complement C3 Proteins 0.000 claims 2
- 102000016918 Complement C3 Human genes 0.000 claims 2
- 108010028778 Complement C4 Proteins 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 108010063045 Lactoferrin Proteins 0.000 claims 2
- 102100032241 Lactotransferrin Human genes 0.000 claims 2
- 102000007562 Serum Albumin Human genes 0.000 claims 2
- 108010071390 Serum Albumin Proteins 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- 239000005556 hormone Substances 0.000 claims 2
- 229940088597 hormone Drugs 0.000 claims 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 2
- 235000021242 lactoferrin Nutrition 0.000 claims 2
- 229940078795 lactoferrin Drugs 0.000 claims 2
- 229920001542 oligosaccharide Polymers 0.000 claims 2
- 150000002482 oligosaccharides Chemical class 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- 235000021247 β-casein Nutrition 0.000 claims 2
- 235000021246 κ-casein Nutrition 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 235000019197 fats Nutrition 0.000 description 23
- 239000000203 mixture Substances 0.000 description 18
- 239000006071 cream Substances 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 8
- 239000012223 aqueous fraction Substances 0.000 description 7
- 210000004291 uterus Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 102000014171 Milk Proteins Human genes 0.000 description 4
- 108010011756 Milk Proteins Proteins 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000021239 milk protein Nutrition 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 235000021073 macronutrients Nutrition 0.000 description 2
- 235000013384 milk substitute Nutrition 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 101100129336 Dictyostelium discoideum malA gene Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 101710202013 Protein 1.5 Proteins 0.000 description 1
- 101100190460 Shigella flexneri pic gene Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 101150086151 hrdB gene Proteins 0.000 description 1
- 230000008902 immunological benefit Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000020190 lactose-free milk Nutrition 0.000 description 1
- 230000036446 length of gestation Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 101150102864 rpoD gene Proteins 0.000 description 1
- 101150117326 sigA gene Proteins 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Pediatric Medicine (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04405567.1 | 2004-09-10 | ||
| EP04405567 | 2004-09-10 | ||
| EP04405592.9 | 2004-09-17 | ||
| EP04405592A EP1637043A1 (en) | 2004-09-17 | 2004-09-17 | Human milk fortifiers and methods for their production |
| PCT/CH2005/000518 WO2006026878A1 (en) | 2004-09-10 | 2005-09-02 | Human milk fortifiers and methods for their production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005282182A1 true AU2005282182A1 (en) | 2006-03-16 |
Family
ID=35511068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005282182A Abandoned AU2005282182A1 (en) | 2004-09-10 | 2005-09-02 | Human milk fortifiers and methods for their production |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20080187619A1 (enExample) |
| EP (1) | EP1791444A1 (enExample) |
| JP (1) | JP2008512398A (enExample) |
| AU (1) | AU2005282182A1 (enExample) |
| WO (1) | WO2006026878A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100268658A1 (en) * | 2001-05-14 | 2010-10-21 | Prolacta Bioscience | Method for collecting, testing and distributing milk |
| US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
| JP2008512656A (ja) * | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳の分析及び処理方法とそのためのシステム |
| BRPI0616323A2 (pt) | 2005-09-20 | 2011-06-14 | Prolacta Bioscience Inc | mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico |
| WO2007116410A2 (en) * | 2006-04-11 | 2007-10-18 | Mileutis Ltd. | Livestock management for improved reproductive efficiency |
| EP2063722B1 (en) * | 2006-08-30 | 2017-05-03 | Prolacta Bioscience, Inc. | Methods of obtaining sterile milk and compositions thereof |
| DK2099321T3 (en) * | 2006-11-29 | 2017-07-17 | Prolacta Bioscience Inc | Human milk compositions and methods for their preparation and use |
| CA2706723C (en) * | 2006-12-08 | 2015-05-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
| CN102300575A (zh) * | 2008-12-02 | 2011-12-28 | 普罗莱克塔生物科学公司 | 人乳渗透物组合物及其制备和使用方法 |
| EP2248908A1 (en) * | 2009-05-05 | 2010-11-10 | Eurolactis Group S.A. | Probiotic microorganisms isolated from donkey milk |
| DK2739157T3 (en) | 2011-08-03 | 2018-01-08 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
| PT2967094T (pt) | 2013-03-13 | 2021-01-14 | Prolacta Bioscience Inc | Produtos de leite humano com elevado teor de matéria gorda |
| US9661868B2 (en) * | 2013-07-16 | 2017-05-30 | Mead Johnson Nutrition Company | Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin |
| ITMI20131690A1 (it) * | 2013-10-14 | 2015-04-15 | Consiglio Nazionale Ricerche | Composizione alimentare. |
| SG10201805732TA (en) * | 2014-01-03 | 2018-08-30 | Elizabeth Rinaldi Schinkel | Method and apparatus for concentrating breast milk |
| EP2957178A1 (en) * | 2014-06-16 | 2015-12-23 | Carag AG | Method and apparatus for preparation of human milk to be stored |
| PL3175238T3 (pl) | 2014-07-28 | 2022-01-17 | Société des Produits Nestlé S.A. | Urządzenia i zestawy do wytwarzania spersonalizowanej, zatężonej kompozycji ludzkiego mleka oraz sposoby jej wytwarzania i stosowania |
| IL303044B2 (en) | 2015-12-30 | 2025-05-01 | Prolacta Bioscience Inc | Human milk products used before and after active treatment |
| US20230103295A1 (en) * | 2016-12-25 | 2023-04-06 | LactaLogics, Inc. | Processing human milk for generating compositions of fortified human milk products |
| KR102004320B1 (ko) * | 2017-09-20 | 2019-07-29 | 건국대학교 글로컬산학협력단 | 모유은행 기증모유의 동결건조보관 방법 |
| MX2021010118A (es) | 2019-02-22 | 2021-11-12 | Aquero Canada Ltd | Composiciones lacteas fortificadas y sus procesos de preparacion. |
| MX2022002949A (es) | 2019-09-24 | 2022-04-06 | Prolacta Bioscience Inc | Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes. |
| AU2021263069A1 (en) * | 2020-04-27 | 2022-11-10 | Société des Produits Nestlé S.A. | Method for producing milk like products |
| BR112022021733A2 (pt) * | 2020-04-27 | 2022-12-06 | Nestle Sa | Método para a produção de produtos semelhantes a leite |
| US11206843B1 (en) * | 2020-05-26 | 2021-12-28 | BIOMILQ, Inc. | Milk product compositions |
| WO2022200526A1 (de) * | 2021-03-24 | 2022-09-29 | Ammeva Gmbh | Getrocknete frauenmilch zum einsatz als nahrungsergänzungsmittel, lebensmittel für besondere medizinische zwecke und als alleinnahrungsmittel für säuglinge |
| US20240196949A1 (en) * | 2021-04-06 | 2024-06-20 | John Kapeleris | Infant formula |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020015A (en) * | 1988-09-22 | 2000-02-01 | Gaull; Gerald E. | Infant formula compositions and nutrition containing genetically engineered human milk proteins |
| US5169666A (en) * | 1991-11-14 | 1992-12-08 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of simulated human milk protein by low temperature microfiltration |
| US6162472A (en) * | 1998-07-28 | 2000-12-19 | University Of Virginia Patent Foundation | Nutritional formula for premature infants and method of making |
| CA2260673A1 (en) * | 1999-02-04 | 2000-08-04 | Natrel Inc. | A process for making a lactose-free milk without negatively affecting the organoleptic properties thereof; and milk so processed |
| US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
| US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
| US6875459B2 (en) * | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
| JP2008512656A (ja) * | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳の分析及び処理方法とそのためのシステム |
-
2005
- 2005-09-02 US US11/662,348 patent/US20080187619A1/en not_active Abandoned
- 2005-09-02 AU AU2005282182A patent/AU2005282182A1/en not_active Abandoned
- 2005-09-02 EP EP05775589A patent/EP1791444A1/en not_active Withdrawn
- 2005-09-02 WO PCT/CH2005/000518 patent/WO2006026878A1/en not_active Ceased
- 2005-09-02 JP JP2007530567A patent/JP2008512398A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006026878A1 (en) | 2006-03-16 |
| EP1791444A1 (en) | 2007-06-06 |
| JP2008512398A (ja) | 2008-04-24 |
| US20080187619A1 (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080187619A1 (en) | Human Milk Fortifiers and Methods for Their Production | |
| AU2022200202B2 (en) | Process for production of improved nutritional products containing milk protein and milk saccharides, and products obtained by the process | |
| EP1637043A1 (en) | Human milk fortifiers and methods for their production | |
| US8377445B2 (en) | Compositions of human lipids and methods of making and using same | |
| Räihä | Nutritional proteins in milk and the protein requirement of normal infants | |
| EP3917338B1 (en) | Native whey protein for improving intestinal maturation | |
| EP3791726A1 (en) | A dry powdered human milk fortifier | |
| Crowley et al. | Potential applications of non‐bovine mammalian milk in infant nutrition | |
| EP3917547A1 (en) | Native whey protein for treating and/or preventing intestinal infection | |
| Räihä | Milk protein quantity and quality and protein requirements during development | |
| CN101014253A (zh) | 人乳强化剂及其生产方法 | |
| EP1637880A1 (en) | Method for analysing and treating human milk and system therefor | |
| EP4057841B1 (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| CN118265463A (zh) | 含有血清蛋白浓缩物的婴儿配方乳粉 | |
| EP2572593B1 (en) | Compositions of human lipids and methods of making and using same | |
| US20220079186A1 (en) | Liquid composition comprised of a micellar casein concentrate | |
| Allegri et al. | Content of non-protein tryptophan in human milk, bovine milk and milk-and soy-based formulas | |
| EP4294214A1 (en) | Milk with a high immunoglobulin content | |
| WO2022078679A1 (en) | Nutritional composition | |
| Räihä | Protein quantity and quality in infant feeding | |
| HK40081708B (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| HK40081708A (en) | Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract | |
| Salle et al. | IN FULL-TERM AND PREMATURE NEWBORNS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |